Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial

AIMS: To examine associations of below-target and target dose of enalapril, an angiotensin-converting enzyme (ACE) inhibitor, with outcomes in patients with heart failure and reduced ejection fraction (HFrEF) in the Studies of Left Ventricular Dysfunction (SOLVD) Treatment trial. METHODS AND RESULTS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Heart Fail
Main Authors: Lam, Phillip H., Dooley, Daniel J., Fonarow, Gregg C., Butler, Javed, Bhatt, Deepak L., Filippatos, Gerasimos S., Deedwania, Prakash, Forman, Daniel E., White, Michel, Fletcher, Ross D., Arundel, Cherinne, Blackman, Marc R., Adamopoulos, Chris, Kanonidis, Ioannis E., Aban, Inmaculada B., Patel, Kanan, Aronow, Wilbert S., Allman, Richard M., Anker, Stefan D., Pitt, Bertram, Ahmed, Ali
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500736/
https://ncbi.nlm.nih.gov/pubmed/28980368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.937
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados